Meglumine antimonate

Clinical data
AHFS/Drugs.com| Micromedex Detailed Consumer Information
ATC code|

* P01CB01 (WHO) Template:ATCvet

Identifiers

IUPAC name

* Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol

CAS Number|

* 133-51-7 N

PubChem CID|

* 64953

ChemSpider|

* 58479 Y

ChEMBL|

* ChEMBL239129 Y

NIAID ChemDB|

* 008733

E number| {{#property:P628}}
ECHA InfoCard| {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula| Variable
Molar mass| Variable
3D model (JSmol)|

* Interactive image

SMILES

* O=[Sb](=O)O.O[C@@H]([C@@H](O)[C@H](O)[C@@H](O)CNC)CO

InChI

* InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1 Y

* Key:XOGYVDXPYVPAAQ-SESJOKTNSA-M Y

NY (what is this?) (verify)

WikiDoc Resources for Meglumine antimonate

Articles

Most recent articles on Meglumine antimonate

Most cited articles on Meglumine antimonate

Review articles on Meglumine antimonate

Articles on Meglumine antimonate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Meglumine antimonate

Images of Meglumine antimonate

Photos of Meglumine antimonate

Podcasts & MP3s on Meglumine antimonate

Videos on Meglumine antimonate

Evidence Based Medicine

Cochrane Collaboration on Meglumine antimonate

Bandolier on Meglumine antimonate

TRIP on Meglumine antimonate

Clinical Trials

Ongoing Trials on Meglumine antimonate at Clinical Trials.gov

Trial results on Meglumine antimonate

Clinical Trials on Meglumine antimonate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Meglumine antimonate

NICE Guidance on Meglumine antimonate

NHS PRODIGY Guidance

FDA on Meglumine antimonate

CDC on Meglumine antimonate

Books

Books on Meglumine antimonate

News

Meglumine antimonate in the news

Be alerted to news on Meglumine antimonate

News trends on Meglumine antimonate

Commentary

Blogs on Meglumine antimonate

Definitions

Definitions of Meglumine antimonate

Patient Resources / Community

Patient resources on Meglumine antimonate

Discussion groups on Meglumine antimonate

Patient Handouts on Meglumine antimonate

Directions to Hospitals Treating Meglumine antimonate

Risk calculators and risk factors for Meglumine antimonate

Healthcare Provider Resources

Symptoms of Meglumine antimonate

Causes & Risk Factors for Meglumine antimonate

Diagnostic studies for Meglumine antimonate

Treatment of Meglumine antimonate

Continuing Medical Education (CME)

CME Programs on Meglumine antimonate

International

Meglumine antimonate en Espanol

Meglumine antimonate en Francais

Business

Meglumine antimonate in the Marketplace

Patents on Meglumine antimonate

Experimental / Informatics

List of terms related to Meglumine antimonate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview

[edit | edit source]

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis.[1] It is manufactured by Aventis[2] and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

## See also

[edit | edit source]

* Meglumine

## References

[edit | edit source]

1. ↑ PMID 9455509 (PMID 9455509)
Citation will be completed automatically in a few minutes.  Jump the queue or expand by hand
2. ↑ Aventis press release, 15 April 2005. Template:De icon

Template:Excavata antiparasitics

Template:Antiinfective-drug-stub
*[CID]: Compound ID